OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
ORVANA REPORTS GEOPHYSICAL SURVEY RESULTS AND COMMENCES INITIAL DEEP DRILLING PROGRAM AT TAGUAS, ARGENTINA
Cruz Battery Metals Enters into Joint Venture Agreement for Deep Basin Lithium Brine Exploration in Clayton Valley, Nevada
